AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimybite M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Redosine Pharmaceutical Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimybite M 2mg/500mg Tablet SR

Diabex Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication is one component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications significantly influence diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms – sweating, lightheadedness, headache, tremors – and appropriate countermeasures. Maintain regular mealtimes and carry a readily available fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Diabex Duo's suitability during pregnancy or breastfeeding requires prior medical consultation. Regular blood glucose monitoring is essential, along with potential blood tests to assess hematologic parameters and liver function.

Uses of Glimybite M 2mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glimybite M 2mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glimybite M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing the tablet. Consume it with food.

Common Side effects of Glimybite M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimybite M 2mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the Glimybite M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume this extended-release tablet with a meal.

How Glimybite M 2mg/500mg Tablet SR works:

Glimbite M 2mg/500mg Extended-Release Tablets combine the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimybite M 2mg/500mg Tablet SR with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimybite M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimybite M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimybite M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician. The use of Glimybite M 2mg/500mg SR tablets is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimybite M 2mg/500mg SR tablets to individuals with hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. In patients exhibiting mild to moderate liver dysfunction, initiate Glimybite M 2mg/500mg SR treatment with a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Glimybite M 2mg/500mg Tablet SR :

Should you forget a dose of Glimybite M 2mg/500mg SR Tablet, ingest it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Never take a double dose.

Facts to Know About Glimybite M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimybite M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimybite M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimybite M and seek immediate medical attention.
Glimybite M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimybite M 2mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimybite M 2mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait problems), urinary issues, cognitive changes, and balance difficulties. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimybite M 2mg/500mg Tablet SR can indeed cause low blood sugar (hypoglycemia). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimybite M 2mg/500mg SR tablets with alcohol is unsafe. Alcohol can exacerbate the medication's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimybite M 2mg/500mg Tab...
74
MRP 90
17% off